Regeneron Antibody Cocktail Proved Effective Against COVID-19
More good news from BCW member Regeneron Pharmaceuticals which this week released a new analysis of data showing that its monoclonal antibody cocktail known as REGEN-COV is effective against Covid-19 infection.
Positive results from a Phase 3 trial jointly run with the National Institute of Allergy and Infectious Diseases showed that the drug reduces by 81.6% the risk of being infected by the Covid-19 virus, SARS-CoV-2. The data are from an ongoing clinical trial in which a group of participants received a 1,200-milligram dose of the drug in four injections administered under the skin.
The clinical trial involved 1,683 people who were tested to be sure they were not infected with Covid and did not have antibodies for the virus. Participants in the trial received either the Regeneron drug or a placebo. It was a double-blind study that initially kept secret the identities of participants who received the monoclonal antibodies and those who did not.
“Today’s new data demonstrate how a single dose of REGEN-COV can help protect people from Covid-19 for many months after administration,” said Myron S. Cohen, a doctor who leads the monoclonal antibody efforts for the Covid Prevention Network, which is sponsored by the National Institutes of Health.
George D. Yancopoulos, President and Chief Scientific Officer at Regeneron, said, “These data add to the increasing body of evidence supporting use of REGEN-COV to prevent Covid-19 in uninfected individuals, which may be especially useful for the many immunocompromised people who do not respond adequately to vaccines. With infections still occurring despite widespread vaccination, the immunocompromised face an ongoing risk of encountering the virus during their daily lives.”
Yancopoulos and Regeneron CEO Leonard Schleifer were awarded the BCW’s 2021 Global Leadership Laureate at last month’s Annual Dinner for their innovation, their development of the REGEN-COV therapy for post-exposure prevention of Covid-19, and for the company’s multi-billion-dollar investments in Westchester County.
Similar News Items
BCW-member ArtsWestchester’s Annual Arts Awards on Wednesday celebrated local organizations, artists and art patrons who power the county’s vibrant cultural scene. The Sonesta White Plains buzzed with energy as over 300 attendees gathered for the event that celebrated ArtsWestchester’s 60th anniversary and artists who champion inclusivity and artistic excellence. “I don’t need to tell you […]
The Business Council of Westchester is among nearly 40 other businesses and business associations across the state. as well as various national groups that have joined with the Business Council of New York State, Inc. in delivering a legislative memo in support of the “Affordable Waste Reduction Act” (S.5062 (Martinez)/A.6191 (Jackson)). The supporting groups have […]
BCW Member WBP Development joined with State, County and Village officials on April 3 for the groundbreaking of Station Plaza, a $96 million transformative project consisting of an eight-story residential building with 108 units and a four-level detached parking garage. Each apartment will be designated for households earning at or below 80 percent of the […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.